System for transvaginal drug delivery
US7004171B2 · kind B2 · utility
26Cited by
11References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 25, 2002 |
| Grant date | Feb 28, 2006 |
| Priority date | — |
| Expiry date | Jul 18, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61F6/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A transvaginal drug delivery system comprising: (a) a deposition comprising an effective amount of said drug and, optionally, a wetting agent; and (b) a polymeric support on which said deposition is deposited. Also disclosed is a catamenial tampon for insertion in a human vagina comprising: (a) an inner core comprising an absorbent material; (b) an outer layer comprising a liquid-permeable material; and (c) a delivery system according to the invention. A method of transvaginal drug delivery is also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.